Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis
Phytotherapy Research · 2026-04 · 40 (4) · 1886-1902
DOI: 10.1002/ptr.70252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 02.02.2026. Verfasst von Zhipeng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Xiangya School of Public Health, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Sesquiterpenes, Endoplasmic Reticulum Stress, Ferroptosis, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Innovation-Driven Project of Central South University.
Abstract (Originalsprache)
Hepatic ferroptosis has emerged as a crucial pathogenic mechanism and severe adverse outcome in metabolic‐associated fatty liver disease (MAFLD). Curcumol (CCM), a sesquiterpenoid phytochemical with potential hepatoprotective properties, remains unexplored for its therapeutic properties in MAFLD management. In this study, the effects and mechanisms of CCM on hepatic ferroptosis in MAFLD were investigated using in silico approaches and evaluated at the cellular and molecular levels using both in vivo and in vitro disease models of MAFLD. Our results showed that hepatic ferroptosis was accompanied by endoplasmic reticulum stress (ERS) in high‐fat‐induced MAFLD. Administration of the ERS inhibitor 4‐PBA significantly alleviated ferroptosis, suggesting the pathogenic role of ERS‐mediated ferroptosis in MAFLD. Notably, CCM exhibited comparable effects to 4‐PBA, indicating that CCM mitigated hepatic ferroptosis through inhibiting ERS. Subsequent data showed that the therapeutic effects of CCM were achieved by targeting epidermal growth factor receptor (EGFR), as evidenced by the phenomenon that the efficacy of CCM was reversed following the administration of an EGFR agonist. In conclusion, this study highlighted the therapeutic effects of CCM on alleviating hepatic ferroptosis in high‐fat‐induced MAFLD by inhibiting the EGFR–ERS axis, and emphasized the promising application of CCM in MAFLD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
ORCID-Profile: Wenya Zheng, Hong Qin
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Innovation-Driven Project of Central South University
- Institute of Genetics
- Chinese Academy of Sciences
Zitieren
APA
Wang, Z., Fu, Y., Zheng, W., Zeng, X., Xu, Z., Chen, J., Liu, X., & Qin, H. (2026). Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis. Phytotherapy Research, 40(4), 1886-1902. https://doi.org/10.1002/ptr.70252
Vancouver
Wang Z, Fu Y, Zheng W, Zeng X, Xu Z, Chen J, et al. Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis. Phytotherapy Research. 2026;40(4):1886-1902. doi:10.1002/ptr.70252
BibTeX
@article{Wang2026,
author = {Wang, Zhipeng and Fu, Yansong and Zheng, Wenya and Zeng, Xin and Xu, Zhuoya and Chen, Jingmiao and Liu, Xi and Qin, Hong},
title = {Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {4},
pages = {1886--1902},
doi = {10.1002/ptr.70252}
}
EUVIMED